Not Signed In - Eisai Licenses Selective Estrogen Receptor Modulators (SERMs) To Radius
Wed, 05 Jul 2006 06:00 AM EST
... Eisai announced June 29 that it signed a license agreement with Radius Health, headquartered in Massachusetts, for the use of Eisai's new class of selective estrogen receptor modulator (SERM). Radius plans to develop the compound as a new therapeutic drug for osteoporosis and malaise such as hot flashes associated with post-menopausal disorders, etc. [click link for full article] ...
Related Topics
- Estrogen Receptor Modulators, Selective
- Estrogen
- Selective Dorsal Rhizotomy
- Estrogen Receptors
- Selective Serotonin Reuptake Inhibitors (SSRIs)
- Estrogen-containing Medications
- Conjugated Estrogen
- Androgen insensitivity syndrome
- Hormone Replacement Therapy
- Thrombocytopenia
- Transferrin
- Information Dissemination
- Follitropin
- Folate
- Conjugated Estrogen Vaginal Cream
- Natural therapies
- Natural therapy
- Thrombophlebitis
- Progesterone
- Estradiol Transdermal System
email this page
print this page
bookmark this page
feedback on this page
